EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity

Miriam Moscoso, Víctor Fuentes-Valverde, Patricia García, Juan A Vallejo, Jesús Pérez-Ortega, Rebeca Santamarina-Fernández, Ana Candela, Marina Oviaño, Jesús Arenas, Germán Bou

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1664169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Miriam Moscoso und 9 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Microbiología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas…. Hauptthemen laut MEDLINE: Lipid A, Pseudomonas aeruginosa, Pseudomonas Vaccines, Pseudomonas Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen responsible for severe respiratory tract infections. We previously developed a live attenuated auxotrophic vaccine candidate, PAO1 Δ murI , which conferred protection in murine infection models but exhibited significant reactogenicity when administered intranasally. To reduce the toxicity of PAO1 Δ murI without compromising its protective efficacy, we engineered strains with a modified lipid A structure, as lipid A is one of the main toxic components of whole-cell vaccines.

Methods

Two lipid A-modifying enzymes, LpxR and PagL were overproduced in PAO1 Δ murI derivatives. The resulting lipopolysaccharide (LPS) was analyzed by MALDI-TOF mass spectrometry. In vitro assays with HEK293-Blue reporter cells expressing murine and human Toll-like receptor 4 (TLR4) were used to assess LPS-associated toxicity, while in vivo reactogenicity and protective efficacy were evaluated in a murine acute pneumonia model.

Results

LPS extracted from the wild-type strain showed heterogeneous lipid A structures with varying degrees of acylation, and a predominant penta-acylated species. Expression of LpxR led to enrichment in tetra-acylated species, while PagL expression reduced the heterogeneity observed in the wild type. Both mutant strains showed decreased TLR4 activation in vitro as compared to the wild type. In mice, lipid A-modified derivatives retained protective efficacy; however, no reduction in reactogenicity was observed.

Discussion

Lipid A modifications mediated by LpxR and PagL attenuated TLR4 signaling in vitro but were insufficient to reduce in vivo reactogenicity. Additional modifications or targeting of other toxic components may be required. This strategy may serve as an initial basis for optimizing live attenuated P. aeruginosa vaccines, although additional approaches will likely be necessary to achieve substantial improvements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid APseudomonas aeruginosaPseudomonas VaccinesPseudomonas InfectionsBacterial ProteinsImmunogenicity, VaccineAcyltransferasesAnimalsMiceHumansVaccines, AttenuatedToll-Like Receptor 4Disease Models, AnimalHEK293 CellsFemaleLipopolysaccharides

Stichwörter der Autor:innen

D-glutamate auxotrophyPseudomonas aeruginosahumoral immunitylipid A modifying-enzymeslipopolysaccharidelive vaccinesprotective efficacyreactogenicity

Substanzen

Lipid APseudomonas VaccinesVaccines, AttenuatedToll-Like Receptor 4Bacterial ProteinsLipopolysaccharidesAcyltransferases

Autor:innen und Institutionen

  • Servicio de Microbiología, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, A Coruña, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
  • Department of Molecular Microbiology, Faculty of Science and Institute of Biomembranes. Utrecht University, Utrecht, Netherlands.
  • Unit of Microbiology and Immunology, Faculty of Veterinary, University of Zaragoza, Agroalimentary Institute of Aragon, IA2. II2, Zaragoza, Spain.
  • Departamento de Fisioterapia, Medicina y Ciencias Biomédicas, Universidad de A Coruña, A Coruña, Spain.

Zitieren

APA

Moscoso, M., Fuentes-Valverde, V., García, P., Vallejo, J. A., Pérez-Ortega, J., Santamarina-Fernández, R., Candela, A., Oviaño, M., Arenas, J., & Bou, G. (2025). LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1664169

Vancouver

Moscoso M, Fuentes-Valverde V, García P, Vallejo JA, Pérez-Ortega J, Santamarina-Fernández R, et al. LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1664169

BibTeX
@article{Moscoso2025,
  author = {Moscoso, Miriam and Fuentes-Valverde, Víctor and García, Patricia and Vallejo, Juan A and Pérez-Ortega, Jesús and Santamarina-Fernández, Rebeca and Candela, Ana and Oviaño, Marina and Arenas, Jesús and Bou, Germán},
  title = {LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1664169}
}
Kostenlos starten →